T S Ahluwalia1, E Lindholm, L C Groop. 1. Department of Clinical Sciences-Diabetes and Endocrinology, Lund University Diabetes Centre, Clinical Research Centre, University Hospital Skane, UMAS, 20502 Malmo, Sweden. Tarun.Ahluwalia@med.lu.se
Abstract
AIMS/HYPOTHESIS: Several genome-wide linkage studies have shown an association between diabetic nephropathy and a locus on chromosome 18q harbouring two carnosinase genes, CNDP1 and CNDP2. Carnosinase degrades carnosine (β-alanyl-L-histidine), which has been ascribed a renal protective effect as a scavenger of reactive oxygen species. We investigated the putative associations of genetic variants in CNDP1 and CNDP2 with diabetic nephropathy (defined either as micro- or macroalbuminuria) and estimated GFR in type 2 diabetic patients from Sweden. METHODS: We genotyped nine single nucleotide polymorphisms (SNPs) and one trinucleotide repeat polymorphism (D18S880, five to seven leucine repeats) in CNDP1 and CNDP2 in a case-control set-up including 4,888 unrelated type 2 diabetic patients (with and without nephropathy) from Sweden (Scania Diabetes Registry). RESULTS: Two SNPs, rs2346061 in CNDP1 and rs7577 in CNDP2, were associated with an increased risk of diabetic nephropathy (rs2346061 p = 5.07 × 10(-4); rs7577 p = 0.021). The latter was also associated with estimated GFR (β = -0.037, p = 0.014), particularly in women. A haplotype including these SNPs (C-C-G) was associated with a threefold increased risk of diabetic nephropathy (OR 2.98, 95% CI 2.43-3.67, p < 0.0001). CONCLUSIONS/ INTERPRETATION: These data suggest that common variants in CNDP1 and CNDP2 play a role in susceptibility to kidney disease in patients with type 2 diabetes.
AIMS/HYPOTHESIS: Several genome-wide linkage studies have shown an association between diabetic nephropathy and a locus on chromosome 18q harbouring two carnosinase genes, CNDP1 and CNDP2. Carnosinase degrades carnosine (β-alanyl-L-histidine), which has been ascribed a renal protective effect as a scavenger of reactive oxygen species. We investigated the putative associations of genetic variants in CNDP1 and CNDP2 with diabetic nephropathy (defined either as micro- or macroalbuminuria) and estimated GFR in type 2 diabeticpatients from Sweden. METHODS: We genotyped nine single nucleotide polymorphisms (SNPs) and one trinucleotide repeat polymorphism (D18S880, five to seven leucine repeats) in CNDP1 and CNDP2 in a case-control set-up including 4,888 unrelated type 2 diabeticpatients (with and without nephropathy) from Sweden (Scania Diabetes Registry). RESULTS: Two SNPs, rs2346061 in CNDP1 and rs7577 in CNDP2, were associated with an increased risk of diabetic nephropathy (rs2346061 p = 5.07 × 10(-4); rs7577 p = 0.021). The latter was also associated with estimated GFR (β = -0.037, p = 0.014), particularly in women. A haplotype including these SNPs (C-C-G) was associated with a threefold increased risk of diabetic nephropathy (OR 2.98, 95% CI 2.43-3.67, p < 0.0001). CONCLUSIONS/ INTERPRETATION: These data suggest that common variants in CNDP1 and CNDP2 play a role in susceptibility to kidney disease in patients with type 2 diabetes.
Authors: Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker Journal: Bioinformatics Date: 2008-10-30 Impact factor: 6.937
Authors: Bart Janssen; Daniela Hohenadel; Paul Brinkkoetter; Verena Peters; Nina Rind; Christine Fischer; Ivan Rychlik; Marie Cerna; Marianna Romzova; Emile de Heer; Hans Baelde; Stephan J L Bakker; Mahmoud Zirie; Eric Rondeau; Peter Mathieson; Moin A Saleem; Jochen Meyer; Hannes Köppel; Sibylle Sauerhoefer; Claus R Bartram; Peter Nawroth; Hans-Peter Hammes; Benito A Yard; Johannes Zschocke; Fokko J van der Woude Journal: Diabetes Date: 2005-08 Impact factor: 9.461
Authors: Irfan Vardarli; Leslie J Baier; Robert L Hanson; Imren Akkoyun; Christine Fischer; Peter Rohmeiss; Ali Basci; Claus R Bartram; Fokko J Van Der Woude; Bart Janssen Journal: Kidney Int Date: 2002-12 Impact factor: 10.612
Authors: Antien L Mooyaart; Ana Zutinic; Stephan J L Bakker; Diana C Grootendorst; Nanne Kleefstra; Irene G M van Valkengoed; Stefan Böhringer; Henk J G Bilo; Friedo W Dekker; Jan Anthonie Bruijn; Gerjan Navis; Bart Janssen; Hans J Baelde; Emile De Heer Journal: Diabetes Date: 2010-03-23 Impact factor: 9.461
Authors: Sudha K Iyengar; Hanna E Abboud; Katrina A B Goddard; Mohammed F Saad; Sharon G Adler; Nedal H Arar; Donald W Bowden; Ravi Duggirala; Robert C Elston; Robert L Hanson; Eli Ipp; W H Linda Kao; Paul L Kimmel; Michael J Klag; William C Knowler; Lucy A Meoni; Robert G Nelson; Susanne B Nicholas; Madeleine V Pahl; Rulan S Parekh; Shannon R E Quade; Stephen S Rich; Jerome I Rotter; Marina Scavini; Jeffrey R Schelling; John R Sedor; Ashwini R Sehgal; Vallabh O Shah; Michael W Smith; Kent D Taylor; Cheryl A Winkler; Philip G Zager; Barry I Freedman Journal: Diabetes Date: 2007-03-15 Impact factor: 9.461
Authors: Eva Riedl; Hannes Koeppel; Paul Brinkkoetter; Paula Sternik; Herbert Steinbeisser; Sibylle Sauerhoefer; Bart Janssen; Fokko J van der Woude; Benito A Yard Journal: Diabetes Date: 2007-06-29 Impact factor: 9.461
Authors: A Alkhalaf; G W D Landman; K J J van Hateren; K H Groenier; A L Mooyaart; E De Heer; R O B Gans; G J Navis; S J L Bakker; N Kleefstra; H J G Bilo Journal: J Nephrol Date: 2014-04-23 Impact factor: 3.902
Authors: Helen C Looker; Marco Colombo; Felix Agakov; Tanja Zeller; Leif Groop; Barbara Thorand; Colin N Palmer; Anders Hamsten; Ulf de Faire; Everson Nogoceke; Shona J Livingstone; Veikko Salomaa; Karin Leander; Nicola Barbarini; Riccardo Bellazzi; Natalie van Zuydam; Paul M McKeigue; Helen M Colhoun Journal: Diabetologia Date: 2015-03-05 Impact factor: 10.122
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: S Alkayyali; M Lajer; H Deshmukh; E Ahlqvist; H Colhoun; B Isomaa; P Rossing; L Groop; V Lyssenko Journal: Diabetologia Date: 2012-10-31 Impact factor: 10.122